Baird Upgrades The Advisory Board Company to Outperform with Price Target $53

Brokerage firm Baird Upgrades its rating on The Advisory Board Company(ABCO). As per the latest information, Baird Raises the price target to $53 per share from a prior target of $50. The shares have been rated Outperform. The rating by the stock financial advisor at Baird was issued on Mar 27, 2017 in a research report to their Investors and Clients.

In a different note, On Mar 10, 2017, SunTrust Robinson Humphrey said it Downgrades its rating on The Advisory Board Company. The shares have been rated ‘Hold’ by the firm.

The Advisory Board Company (ABCO) remained unchanged at the close of Friday session. Even as the volume increased to 9,14,457 ,the shares failed to make any impression and ended at 0 points or 0.00% at $44.7. The trading session commenced at $44.75 and the stock hit a high of $49.25 and touched $44.4 at the lower end. Considering that the stock pared all of the losses, it can be said as a positive sign. The share price has a 52-week high of $51.225 and the 52-week low is $24.85. The company has a market cap of $1,799 M and has approximately 4,02,35,820 outstanding shares.

The Advisory Board Company(ABCO) last announced its earnings results on Feb 28, 2017 for Fiscal Year 2016 and Q4.Company reported revenue of $203.852M. Analysts had an estimated revenue of $205.150M. Earnings per share were $1.03. Analysts had estimated an EPS of $0.56.

Several Insider Transactions has been reported to the SEC. On Mar 20, 2017, Cormac F Miller (Chief Product Officer) sold 8,160 shares at $44.83 per share price.Also, On Mar 20, 2017, David L Felsenthal (President) sold 32,000 shares at $45.01 per share price.On Feb 15, 2017, Robert W Musslewhite (Chief Executive Officer) sold 5,500 shares at $47.24 per share price, according to the Form-4 filing with the securities and exchange commission.

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues including physician alignment and engagement network management and growth strategy value-based care and population health revenue cycle clinical operations and supply chain. Its higher education programs support colleges and universities in enrollment management academic programming and student learning faculty recruitment and retention student advising and success alumni affairs and advancement and college and university operations. The Company offers approximately 65 distinct membership programs across four areas which include best practices research and insight performance technology software consulting and management services and data- and tech-enabled services. Its best practices research and insight programs provide the foundation for all of its other programs.

Add Comment